Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
05/2003
05/15/2003CA2465950A1 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2462158A1 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
05/14/2003EP1310799A1 In vitro screening for ligands of the estrogen receptor
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310509A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
05/14/2003EP1310508A2 Estrogen sulfamate sulphatase inhibitors
05/14/2003EP1310494A1 PPAR (delta) ACTIVATORS
05/14/2003EP1310257A2 Hormonal contraceptive combination
05/14/2003EP1309704A2 Regulation of human membrane-type serine protease
05/14/2003EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses
05/14/2003EP1309618A2 Leucine-based motif and clostridial neurotoxins
05/14/2003EP1309607A2 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309571A1 Non-steroidal inflammation inhibitors
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309553A1 New aporphine esters and their use in therapy
05/14/2003EP1309544A1 Compounds acting as melanocortin receptor ligands
05/14/2003EP1309347A2 Method and composition for altering a b cell mediated pathology
05/14/2003EP1309324A2 Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x
05/14/2003EP1309316A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
05/14/2003EP1165595B1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486
05/14/2003EP0873330B1 Diarylalkenylamine derivatives
05/14/2003CN1418213A Crgstalline form II of cabergoline
05/14/2003CN1418192A Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof
05/14/2003CN1418185A Aniline-derived ligands for thyroid receptor
05/14/2003CN1418107A Use of FSH for treating infertility
05/14/2003CN1416895A Slow releasing microballoon injection of fish mature accelerating hormone and its prepn
05/14/2003CN1108154C Drug composition for curing gynaecological vaginitis
05/13/2003US6563008 Biphenyl compounds and their use as oestrogenic agents
05/13/2003US6562946 Human procalcitonin and the preparation and use thereof
05/13/2003US6562857 Cyanopyrroles
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562380 Methods for treating or reducing prediposition to breast cancer, pre-menstrual syndrome or symptoms associated with menopause by administration of phyto-estrogen
05/13/2003US6562367 Solvent free formulation; minimum thermal exposure; high bioavailability; sustained release
05/13/2003CA2173863C 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003037928A2 Analogs of human growth hormone-releasing hormone, their preparation and use
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037887A1 Therapeutic isoquinoline compounds
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors
05/08/2003WO2003037433A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/08/2003WO2003037432A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037351A1 Heterocyclo-alkylsulfonyl pyrazoles and their use as cox-2 inhibitors
05/08/2003WO2003037335A1 5-heteroatom-substituted pyrazoles
05/08/2003WO2003037303A1 Spray drying methods and compositions thereof
05/08/2003WO2002081499A3 Somatostatin agonists
05/08/2003WO2002057226A3 68730 and 69112 protein kinase molecules and uses therefor
05/08/2003WO2002024715A3 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
05/08/2003US20030088097 E.g., tert-butyloxycarbonyl-protected 2-(2,2,2-trifluoroethyl)hexahydroimidazo(1,5-a)pyrazine
05/08/2003US20030087963 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087903 Mevinolin derivatives
05/08/2003US20030087901 Compounds and methods for modulation of estrogen receptors
05/08/2003US20030087892 Condensed azepines as vasopressin agonists
05/08/2003US20030087886 Orally active androgens
05/08/2003US20030087885 Treating sexual disorders
05/08/2003US20030087801 Methods for treatment using novel ligands of the neuropeptide receptor hfgan72
05/08/2003US20030087303 In vitro screening for ligands of the estrogen receptor
05/08/2003CA2465632A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
05/08/2003CA2465350A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003CA2465344A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
05/08/2003CA2465040A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003CA2464944A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003CA2464656A1 Spray drying methods and compositions thereof
05/08/2003CA2464342A1 Therapeutic isoquinoline compounds
05/08/2003CA2426785A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/07/2003EP1308445A1 5-heteroatom-substituted pyrazoles
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1307559A2 Slit-like protein obtained from a cdna library from hs-5 stromal cell line
05/07/2003EP1307486A2 Somatostatin analogues
05/07/2003EP1307471A1 16alpha-methyl or ethyl substituted estrogens
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307426A1 Amino diphenyl ethers and amido diphenyl ethers
05/07/2003EP1307229A1 Combination preparation with an er-beta selective estrogen and a serm or antiestrogen
05/07/2003EP1307193A1 Agonists of follicle stimulating hormone activity
05/07/2003EP1307183A2 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
05/07/2003EP1135154B1 Improvement of folliculogenesis
05/07/2003EP1112251B1 Azetidine derivatives, preparation and medicines containing them
05/07/2003EP1107775B1 Composition containing pyrrolizidine-alkaloid-free petasites
05/07/2003EP0835114B1 Pharmaceutical combined preparation, kit and method for hormonal contraception
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003EP0665729B1 Biocompatible polymers containing diagnostic or therapeutic moieties
05/07/2003CN1416416A Androgen receptor suppressors in treatment of hirsutism,acne and androgenetic alopecia
05/07/2003CN1415356A Medicament containing snail powder
05/07/2003CN1415227A Candy with flavor of body fragrant
05/07/2003CN1107669C 维生素d类似物 Vitamin d analogues
05/07/2003CN1107525C Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for release of 17-ÔÇÿbeta'-estradiol to human organism
05/06/2003US6559181 A method to treat endometrial carcinoma, prostate cancer, or prostate hyperplasia comprising administering to a patient in need of such treatment an effective dose of a 3,4-Diphenyl-bicyclo(4.3.0)nonyl compound of formula I
05/06/2003US6559157 Dihydronaphthalene compounds
05/06/2003US6559150 Growth hormone secretagogues
05/06/2003US6558952 Expansion of preferential pancreatic cells; generate nutrient broth, inoculate with pancreatic cells and gastrin receptor ligand, monitor propagation of pancreatic cells
05/02/2003EP1306089A1 Combination of benzimidazoles having angiotensin-II antagonistic activity with diuretics or calcium antagonists
05/02/2003EP1306088A1 Combination of a benzimidazole having angiotensin-II antagonistic activity with a diuretic
05/02/2003EP1305425A2 Drug metabolizing enzymes
1 ... 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 ... 290